| Dr David-alan Coias Rubin, MD | |
|
1325 E Fortification St, Jackson, MS 39202-2442 | |
| (601) 354-4488 | |
| Not Available |
| Full Name | Dr David-alan Coias Rubin |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 8 Years |
| Location | 1325 E Fortification St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851740443 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 29656 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Health Home Health | Arlington, TX | Home health agency |
| Baylor Scott And White Orthopedic And Spine Hospi | Arlington, TX | Hospital |
| Methodist Charlton Medical Center | Dallas, TX | Hospital |
| Baylor Scott & White Medical Center At Irving | Irving, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arlington Orthopedic Associates Pa | 9739161704 | 58 |
News Archive
Is the US health system comprehensively meeting the needs of returning veterans? With the recent attention to mental illness in returning soldiers, and post traumatic stress disorder (PTSD) in particular, little research has focused on the medical care needs of those returning from Operation Enduring Freedom/Operation Iraqi Freedom, according to Dr. Susan Frayne, from the VA Palo Alto Health Care System and Stanford University, and colleagues.
The new therapy strategy for primary sclerosing cholangitis, a liver disease that at present still cannot be cured with medication, shows initial measureable success with the nor-ursodeoxycholic acid (norUrso).
A research paper published in the American Journal of Infection Control says a systematic approach to preparing patients for surgery can reduce both secondary, hospital-acquired patient infections and related healthcare expenses nationwide.
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has entered into a Cooperative Research and Development Agreement with the Naval Medical Research Center. NMRC will collaborate with Genocea to identify antigens that will be used in the development of a vaccine candidate against Plasmodium falciparum for the prevention of malaria.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
› Verified 9 days ago
| Entity Name | Arlington Orthopedic Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336134469 PECOS PAC ID: 9739161704 Enrollment ID: O20040603000398 |
News Archive
Is the US health system comprehensively meeting the needs of returning veterans? With the recent attention to mental illness in returning soldiers, and post traumatic stress disorder (PTSD) in particular, little research has focused on the medical care needs of those returning from Operation Enduring Freedom/Operation Iraqi Freedom, according to Dr. Susan Frayne, from the VA Palo Alto Health Care System and Stanford University, and colleagues.
The new therapy strategy for primary sclerosing cholangitis, a liver disease that at present still cannot be cured with medication, shows initial measureable success with the nor-ursodeoxycholic acid (norUrso).
A research paper published in the American Journal of Infection Control says a systematic approach to preparing patients for surgery can reduce both secondary, hospital-acquired patient infections and related healthcare expenses nationwide.
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has entered into a Cooperative Research and Development Agreement with the Naval Medical Research Center. NMRC will collaborate with Genocea to identify antigens that will be used in the development of a vaccine candidate against Plasmodium falciparum for the prevention of malaria.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David-alan Coias Rubin, MD 1325 E Fortification St, Jackson, MS 39202-2442 Ph: (601) 354-4488 | Dr David-alan Coias Rubin, MD 1325 E Fortification St, Jackson, MS 39202-2442 Ph: (601) 354-4488 |
News Archive
Is the US health system comprehensively meeting the needs of returning veterans? With the recent attention to mental illness in returning soldiers, and post traumatic stress disorder (PTSD) in particular, little research has focused on the medical care needs of those returning from Operation Enduring Freedom/Operation Iraqi Freedom, according to Dr. Susan Frayne, from the VA Palo Alto Health Care System and Stanford University, and colleagues.
The new therapy strategy for primary sclerosing cholangitis, a liver disease that at present still cannot be cured with medication, shows initial measureable success with the nor-ursodeoxycholic acid (norUrso).
A research paper published in the American Journal of Infection Control says a systematic approach to preparing patients for surgery can reduce both secondary, hospital-acquired patient infections and related healthcare expenses nationwide.
Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has entered into a Cooperative Research and Development Agreement with the Naval Medical Research Center. NMRC will collaborate with Genocea to identify antigens that will be used in the development of a vaccine candidate against Plasmodium falciparum for the prevention of malaria.
Puma Biotechnology, Inc., a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in combination with the anticancer drugs paclitaxel and trastuzumab in patients with metastatic HER-2 positive breast cancer were presented in a poster presentation at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.
› Verified 9 days ago
Dr. Trevor Reed Pickering, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-354-4488 Fax: 601-960-4586 | |
Latoya Braylock, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-6525 | |
Dr. Larry Daniel Field, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-354-4488 Fax: 601-914-1861 | |
Dr. James William Woodall Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-949-9106 Fax: 601-914-1835 | |
Kevin Francis Purcell, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-6525 | |
Dr. Spencer Montgomery, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-6525 | |
Dr. E Frazier Ward, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Orthopaedic Surgery, Jackson, MS 39216 Phone: 601-984-6525 Fax: 601-984-5151 |